Provider transparency checklist
Ten questions that separate a transparent compounded tirzepatide provider from a careless one. Print it, then run every provider through it.
Before you enroll, confirm:
- Does the provider disclose full pricing?
Look for the price at every dose, not just a starter rate. Vague or login-gated pricing is a warning sign. - Does pricing increase by dose?
Ask for the price at 5, 10 and 15 mg. Flat-rate providers give one number; dose-tiered providers give a schedule. - Are labs included?
Confirm whether lab review is bundled or billed separately. - Are provider visits included?
Confirm whether visits are included or charged per consult. - Is shipping included?
Confirm standard and expedited/cold-chain shipping costs. - Is the pharmacy named?
A reputable provider names its 503A/503B pharmacies and can supply certificates of analysis. - Are cancellation and refund terms clear?
Especially on longer plans — can you stop, and is the unused portion refundable? - Are compounded-medication disclaimers visible?
The provider should state plainly that compounded tirzepatide is not FDA-approved. - Is there ongoing provider access?
Confirm follow-up for titration and side-effects, not just a one-time prescription. - Are clinical claims medically reviewed?
Look for a named medical reviewer and dated review.
Common questions
How do I choose a compounded tirzepatide provider?
Work through a transparency checklist: full pricing disclosed, whether price rises by dose, what's included (labs, visits, shipping), named 503A/503B pharmacy, clear cancellation terms, visible not-FDA-approved disclaimer, ongoing access, and medically reviewed claims.
What is the biggest red flag with online tirzepatide providers?
Opacity about the pharmacy — an unnamed pharmacy, no 503A/503B status, and no certificate of analysis. Because compounded tirzepatide isn't FDA-approved, pharmacy transparency is the key quality signal.